QUEST DIAGNOSTICS INC
For the period ended Dec 31, 2023. Filed Feb 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 22, 2024
DGX$258.44-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders' Equity
| Quest Diagnostics Stockholders’ Equity | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares ofCommonStock Out-standing · CommonStock · AdditionalPaid-InCapital · RetainedEarnings · AccumulatedOtherComprehensive Loss · TreasuryStock, atCost · Non-controllingInterests · Total Stock-holders’Equity · Redeemable Non-controlling Interest | |||||||||||||
| Balance, December 31, 2020 | 133 | $2 | $2,841 | $9,303 | $(21) | $(5,366) | $50 | $6,809 | $82 | ||||
| Net income | 1,995 | 72 | 2,067 | 13 | |||||||||
| Other comprehensive income, net of tax | 7 | 7 | |||||||||||
| Dividends declared | (307) | (307) | |||||||||||
| Distributions to noncontrolling interest partners | (83) | (83) | (16) | ||||||||||
| Issuance of common stock under benefit plans | (21) | 47 | 26 | ||||||||||
| Stock-based compensation expense | 79 | 79 | |||||||||||
| Exercise of stock options | 2 | 20 | 109 | 129 | |||||||||
| Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans | (10) | (12) | (22) | ||||||||||
| Purchase of treasury stock | (16) | (2,222) | (2,222) | ||||||||||
| Retirement of treasury stock | (649) | (3,342) | 3,991 | — | |||||||||
| Balance, December 31, 2021 | 119 | $2 | $2,260 | $7,649 | $(14) | $(3,453) | $39 | $6,483 | $79 | ||||
| Net income | 946 | 62 | 1,008 | 7 | |||||||||
| Other comprehensive loss, net of tax | (7) | (7) | |||||||||||
| Dividends declared | (305) | (305) | |||||||||||
| Distributions to noncontrolling interest partners | (64) | (64) | (9) | ||||||||||
| Issuance of common stock under benefit plans | 1 | (36) | 64 | 28 | |||||||||
| Stock-based compensation expense | 77 | 77 | |||||||||||
| Exercise of stock options | 1 | 4 | 119 | 123 | |||||||||
| Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans | (10) | (18) | (28) | ||||||||||
| Purchases of treasury stock | (10) | (1,385) | (1,385) | ||||||||||
| Balance, December 31, 2022 | 111 | $2 | $2,295 | $8,290 | $(21) | $(4,673) | $37 | $5,930 | $77 | ||||
| Net income | 854 | 49 | 903 | 5 | |||||||||
| Other comprehensive income, net of tax | 7 | 7 | |||||||||||
| Dividends declared | (319) | (319) | |||||||||||
| Distributions to noncontrolling interest partners | (51) | (51) | (6) | ||||||||||
| Issuance of common stock under benefit plans | 1 | (39) | 66 | 27 | |||||||||
| Stock-based compensation expense | 77 | 77 | |||||||||||
| Exercise of stock options | 1 | (3) | 75 | 72 | |||||||||
| Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans | (10) | (18) | (28) | ||||||||||
| Purchases of treasury stock | (2) | (276) | (276) | ||||||||||
| Balance, December 31, 2023 | 111 | $2 | $2,320 | $8,825 | $(14) | $(4,826) | $35 | $6,342 | $76 | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.